GSK Pharma Sept qtr PAT seen up 5% at Rs 165.5 cr
Dolat Capital has come out with its earning estimates on Pharma sector for the quarter ended September 2011. According to the research firm, GSK Pharma September quarter net sales are expected to go up by 10.3% at Rs 650 crore, year-on-year, (YoY) basis.